Logo-ipp

Immunopathol Persa. 2022;8(2): e15207. doi: 10.34172/ipp.2022.15207

Original

Evaluation of the urine mRNA-PCA3 expression level in prostate patients; comparison between benign prostatic hyperplasia and cancer

Amid Yazdani 1 ORCID, Farshad Namdari 2, Sattar Gorgani-Firuzjaee 3, Hassan Niroomand 1 * ORCID

Cited by CrossRef: 3

1- Yang M, Zhang Y, Li M, Liu X, Darvishi M. The various role of microRNAs in breast cancer angiogenesis, with a special focus on novel miRNA-based delivery strategies. Cancer Cell Int. 2023;23(1) [Crossref]
2- Bao S, Darvishi M, H Amin A, Al-Haideri M, Patra I, Kashikova K, Ahmad I, Alsaikhan F, Al-qaim Z, Al-Gazally M, Kiasari B, Tavakoli-Far B, Sidikov A, Mustafa Y, Akhavan-Sigari R. CXC chemokine receptor 4 (CXCR4) blockade in cancer treatment. J Cancer Res Clin Oncol. 2023;149(10):7945 [Crossref]
3- Ghasemi Darestani N, Gilmanova A, Al-Gazally M, Zekiy A, Ansari M, Zabibah R, Jawad M, Al-Shalah S, Rizaev J, Alnassar Y, Mohammed N, Mustafa Y, Darvishi M, Akhavan-Sigari R. Mesenchymal stem cell-released oncolytic virus: an innovative strategy for cancer treatment. Cell Commun Signal. 2023;21(1) [Crossref]